| NCT04548791 | Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Inherited Bleeding Disorders | TERMINATED | PHASE1, PHASE2 | 2021-05-17 | 2021-12-03 | 2021-11-15 |
| NCT04489537 | Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Hemophilia A or B | TERMINATED | PHASE3 | 2021-05-04 | 2021-12-01 | 2021-11-15 |
| NCT04072237 | Study of Coagulation Faction VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia | COMPLETED | PHASE1 | 2019-09-24 | 2020-06-17 | 2020-04-30 |
| NCT03995784 | Study of Next-Generation Recombinant Factor IX Variant in Adult Subjects With Hemophilia B | COMPLETED | PHASE2 | 2019-06-18 | 2020-04-30 | 2020-02-28 |
| NCT03819660 | Long Term Safety of Amifampridine Phosphate in Spinal Muscular Atrophy 3 | TERMINATED | PHASE2 | 2019-03-07 | 2021-09-13 | 2021-09-13 |
| NCT03781479 | Controlled Trial to Evaluate Amifampridine Phosphate in Spinal Muscular Atrophy Type 3 Patients | COMPLETED | PHASE2 | 2019-01-21 | 2020-07-23 | 2020-07-23 |
| NCT03579966 | Long Term Safety Study of Amifampridine Phosphate in MuSK-MG (Muscle Specific Tyrosine Kinase Myasthenia Gravis) | TERMINATED | PHASE3 | 2018-06-11 | 2022-08-05 | 2022-08-05 |
| NCT03304054 | Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MG | COMPLETED | PHASE3 | 2018-04-18 | 2020-03-15 | 2020-01-31 |
| NCT03407651 | Study of Coagulation Factor VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia A and B | COMPLETED | PHASE2 | 2017-12-18 | 2019-04-13 | 2019-03-15 |
| NCT02970162 | Phase 3 Study to Evaluate Efficacy of Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS) | COMPLETED | PHASE3 | 2016-11 | 2017-10 | 2017-10 |
| NCT02562066 | Amifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes | COMPLETED | PHASE3 | 2016-01 | 2019-10 | 2019-08 |
| NCT01493596 | A Safety, Tolerability and Pharmacokinetic Study of CPP-115 | COMPLETED | PHASE1 | 2011-12 | 2012-08 | 2012-06 |
| NCT01439971 | Phase 1 Safety, Pharmacokinetics And Pharmacodynamics Study Of Recombinant Factor VIIa Variant (813d) In Adult Subjects With Hemophilia | COMPLETED | PHASE1 | 2011-12 | 2015-10 | 2015-10 |
| NCT01377922 | A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS) | COMPLETED | PHASE3 | 2011-06 | 2016-07 | 2016-07 |
| NCT00730522 | Safety and Efficacy Study of Vigabatrin to Treat Methamphetamine Dependence | TERMINATED | PHASE2 | 2008-07 | 2009-11 | 2009-06 |
| NCT00611130 | Vigabatrin for Treatment of Cocaine Dependence | COMPLETED | PHASE2 | 2008-01 | 2012-10 | 2009-05 |